ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 201 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,842,357 | -41.9% | 1,786,414 | 0.0% | 0.88% | -42.8% |
| Q2 2023 | $13,487,426 | +3.6% | 1,786,414 | 0.0% | 1.53% | +2.3% |
| Q1 2023 | $13,022,958 | -28.5% | 1,786,414 | 0.0% | 1.50% | -27.4% |
| Q4 2022 | $18,221,423 | -54.6% | 1,786,414 | -52.2% | 2.07% | -58.8% |
| Q3 2022 | $40,129,000 | -9.6% | 3,736,414 | -2.6% | 5.01% | -1.6% |
| Q2 2022 | $44,387,000 | +28.3% | 3,836,414 | 0.0% | 5.09% | +51.0% |
| Q1 2022 | $34,604,000 | -23.7% | 3,836,414 | 0.0% | 3.37% | -22.7% |
| Q4 2021 | $45,346,000 | -40.9% | 3,836,414 | 0.0% | 4.36% | -45.2% |
| Q3 2021 | $76,767,000 | -5.7% | 3,836,414 | -3.5% | 7.97% | -4.5% |
| Q2 2021 | $81,428,000 | – | 3,975,994 | – | 8.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |